Patent Assignment
Reel/Frame 075026/0859
Assignment of Assignor's Interest
Recorded: 2026-06-22
Pages: 3
Assignor
TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
Executed: 2022-12-13
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Anti-Vedolizumab Antibodies and Uses Thereof
Patent:
12,693,298 →
Application:
18/148,109 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.